Page 4«..3456..1020..»


Category Archives: Hypogonadism

Covid-19 Impact on Global Testosterone Cypionate Market by Product Type, With Production, Revenue, Price, Industry Share and Growth Rate, Analysis…


Posted: September 7, 2020 at 11:55 am

This thorough and in-depth presentation on the global Testosterone Cypionate market is a ready-to-refer market research presentation that offers high end cues and actionable insights to various market participants and players operating across regional and global areas to secure growth, sustenance and uncompromised revenue pools. Continue reading

Posted in Hypogonadism | Comments Off on Covid-19 Impact on Global Testosterone Cypionate Market by Product Type, With Production, Revenue, Price, Industry Share and Growth Rate, Analysis…

Vogelzang Discusses Treatment Choices for mCRPC in the Frontline and Beyond – Targeted Oncology


Posted: August 31, 2020 at 5:53 am

During a virtual Case Based Peer Perspectives event, Nicholas J. Continue reading

Posted in Hypogonadism | Comments Off on Vogelzang Discusses Treatment Choices for mCRPC in the Frontline and Beyond – Targeted Oncology

Hormone Replacement Therapy Market: Rising incidences of hormonal imbalance disorders is the primary drivers of this market – BioSpace


Posted: August 31, 2020 at 5:53 am

Global Hormone Replacement Therapy Market: Overview Hormone replacement therapy refers to the treatment of the patients with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low. Currently, a combination of drugs are used to treat hormone deficiencies, which are known to have better safety and efficacy parameter. Globally, the cases of hormone deficiency is escalating and a vast patient base are deprived of the proper treatment. Continue reading

Posted in Hypogonadism | Comments Off on Hormone Replacement Therapy Market: Rising incidences of hormonal imbalance disorders is the primary drivers of this market – BioSpace

International honour for Sheffield pioneer of therapy for children with chronic hormone deficiency – indiaeducationdiary.in


Posted: August 29, 2020 at 5:54 pm

A scientist from the University of Sheffield who pioneered the first licenced therapy for children with a chronic hormone deficiency has been honoured with a prestigious international award. Richard Ross, Professor of Endocrinology at the University of Sheffield, has been recognised with the 2021 Outstanding Innovation Laureate Award from the Endocrine Society one of the top honours in the field. Continue reading

Posted in Hypogonadism | Comments Off on International honour for Sheffield pioneer of therapy for children with chronic hormone deficiency – indiaeducationdiary.in

LPCN: Tlando: Target Action Date This Friday – Zacks Small Cap Research


Posted: August 25, 2020 at 11:56 pm

By John Vandermosten NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT Up and Coming Milestones Tlando PDUFA date August 28, 2020 Primary endpoint results for LiFT (LPCN 1144) 4Q:20 Patent Infringement trial February 2021 Complete Phase II LiFT (LPCN 1144) 2Q:21 Second Quarter 2020 Operational and Financial Results On August 6, 2020 Lipocine (NASDAQ:LPCN) filed its second quarter 2020 10-Q and posted its earnings release for the three month period ending June 30, 2020. The company reported zero revenues and a net loss per share of ($0.13) compared to prior year revenues of zero and loss of ($0.14) per share. Continue reading

Posted in Hypogonadism | Comments Off on LPCN: Tlando: Target Action Date This Friday – Zacks Small Cap Research

UB diabetes expert’s research shows testosterone therapy can lead to remission in men with Type 2 diabetes – UB News Center


Posted: July 30, 2020 at 12:59 pm

BUFFALO, N.Y. Continue reading

Posted in Hypogonadism | Comments Off on UB diabetes expert’s research shows testosterone therapy can lead to remission in men with Type 2 diabetes – UB News Center

Aytu BioScience Announces Regulatory Approval of ZolpiMist(R) by Australian Therapeutic Goods Administration – Yahoo Finance


Posted: July 30, 2020 at 12:59 pm

Aytu BioScience's Sublicensee SUDA Pharmaceuticals Secures TGA Approval, Enabling Near-Term Commercialization of ZolpiMist ENGLEWOOD, CO / ACCESSWIRE / July 30, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the "Company") focused on commercializing novel products that address significant patient needs, today announced the approval of ZolpiMist (zolpidem tartrate oral spray) by the Therapeutic Goods Administration (TGA) in Australia. This approval, which was secured by the Company's ZolpiMist sublicensee SUDA Pharmaceuticals Ltd ("SUDA"), enables near-term commercialization of ZolpiMist in Australia. Continue reading

Posted in Hypogonadism | Comments Off on Aytu BioScience Announces Regulatory Approval of ZolpiMist(R) by Australian Therapeutic Goods Administration – Yahoo Finance

What is Male Menopause? Heres everything you need to know about andropause – PINKVILLA


Posted: July 25, 2020 at 4:55 pm

Andropause or male menopause has to do with the declining hormonal levels in older men. Read on to know the symptoms, causes and treatment of this condition. We often talk about how women suffer from menopause and how it affects their health. Continue reading

Posted in Hypogonadism | Comments Off on What is Male Menopause? Heres everything you need to know about andropause – PINKVILLA

Impact of Covid-19 on Male Hypogonadism market 2020 | What are the key challenges to the Industry growth? – Bulletin Line


Posted: July 25, 2020 at 4:55 pm

Male Hypogonadism Market Industry Forecast To 2026 Garner Insights has titled a new research report named as Male Hypogonadism Market 2020 to its consistently extending database. The report clarifies this through a series of channels which include data ranging from rudimentary data to an undeniable estimate Continue reading

Posted in Hypogonadism | Comments Off on Impact of Covid-19 on Male Hypogonadism market 2020 | What are the key challenges to the Industry growth? – Bulletin Line

Male Hypogonadism Market expected to Witness a Sustainable Growth over 2017 – 2026 – Techinfeed


Posted: July 7, 2020 at 5:59 pm

The global Male Hypogonadism market study presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Male Hypogonadism market player in a comprehensive way. Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Market expected to Witness a Sustainable Growth over 2017 – 2026 – Techinfeed

Page 4«..3456..1020..»